Fund Name

$ Value

% Port.

COM NEW

STOCK

$ Bought

% Increased

% Reduced

$ Sold

Shares

Percent

Date

Type

% Portfolio

% Chg

$ Change

$ Held

# Shares

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of liver fibrosis associated with a broad spectrum of chronic liver diseases in the United States and internationally. It develops Hydronidone, that has completed phase 1 clinical trial for the treatment of nonalcoholic steatohepatitis, a severe form of nonalcoholic fatty liver disease. The company was founded in 2002 and is headquartered in South San Francisco, California.

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of liver fibrosis ass...

Datesorted ascending	Fund Name	Type	% Portfolio	% Chg	$ Change	$ Held	# Shares
2024-05-06	Advisory Services Network, LLC	SOLD OFF	Premium	Premium	Premium	Premium	-
2023-03-17	American Portfolios Advisors	UNCHANGED	Premium	Premium	Premium	Premium	215
2021-08-03	Johnson & Johnson Innovation - JJDC, Inc.	UNCHANGED	Premium	Premium	Premium	Premium	66,951

Fund Name	# Shares	$ Value	% Port.
Johnson & Johnson Innovation - JJDC, Inc.	66,951	290,000	0.03%
American Portfolios Advisors	215	108	-
Advisory Services Network, LLC	-	-	-

Fund Name	$ Value	% Port.
Johnson & Johnson Innovation - JJDC, Inc.	290,000	0.03%
American Portfolios Advisors	108	-
Advisory Services Network, LLC	-	-

CBIO - Catalyst Biosciences Inc Stock Price, Fair Value and News

Which funds bought or sold CBIO recently?

Which funds are the top buyers of CBIO?

Which funds have put a big percent of portfolio in CBIO?

Trend of No. of funds that hold CBIO

Changes in Positions

Investor Breakout

Investor Churn (# Increased Holdings)

Sold off